Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
233.4 SEK | +4.66% | -2.34% | -12.85% |
May. 17 | Transcript : BioArctic AB, Q1 2024 Earnings Call, May 17, 2024 | |
May. 17 | BioArctic AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar BioArctic AB
Upcoming events on BioArctic AB
Past events on BioArctic AB
2024-05-22 10:30 am | Annual General Meeting |
2024-05-17 03:30 am | Q1 2024 Earnings Call |
2024-05-17 02:00 am | Q1 2024 Earnings Release |
2024-03-09 04:25 am | Alzheimer and Parkinson Diseases International Conference - Structural dynamics of amyloid-? protofi |
2024-03-09 04:10 am | Alzheimer and Parkinson Diseases International Conference - Lecanemab for the treatment of early Alz |
2024-03-09 03:40 am | Alzheimer and Parkinson Diseases International Conference - Binding characteristics of lecanemab, do |
2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation : P0111 / #943 |
2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation P0110 / #562 |
2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation P0213 / #1510 |
2024-03-07 10:20 am | Alzheimer and Parkinson Diseases International Conference - Novel approaches to clinical development |
2024-03-07 08:50 am | Alzheimer and Parkinson Diseases International Conference - Treatment with lecanemab disrupts tau ac |
2024-03-07 06:10 am | Alzheimer and Parkinson Diseases International Conference - Defining meaningful benefits to patients |
2024-03-04 | Alzheimer and Parkinson Diseases International Conference |
2024-02-14 03:30 am | Q4 2023 Earnings Call |
2024-02-14 02:00 am | Q4 2023 Earnings Release |
2024-02-05 11:08 pm | Q4 2023 Sales and Revenue Release |
2023-11-08 03:30 am | Q3 2023 Earnings Call |
2023-11-08 02:00 am | Q3 2023 Earnings Release |
2023-11-06 11:16 pm | Q3 2023 Sales and Revenue Release |
2023-10-26 02:50 pm | Clinical Trials on Alzheimer Disease Conference |
Past dividends on BioArctic AB
2019-05-09 | Annual 1.5 SEK |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 282 294 -4.07% | 65,9 57,6 14.46% | 23,1 121 -80.83% | 230 220 4.71% | 616 559 10.2% | 526 |
EBITDA Million SEK | Released Forecast Spread | 122 71,6 70.05% | -74,0 -152 51.22% | -127 -60,2 -110.39% | -2,81 -10,5 73.25% | 271 277 -2.06% | -0,40 |
EBIT Million SEK | Released Forecast Spread | 113 72,3 55.54% | -85,0 -151 43.69% | -140 -59,5 -134.88% | -17,4 -78,1 77.68% | 253 264 -4.42% | 9,41 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 113 72,2 56.52% | -86,7 -152 42.92% | -141 -60,3 -132.92% | -11,2 -34,1 67.22% | 276 209 32.35% | -2,78 |
Net income Million SEK | Released Forecast Spread | 88,5 56,4 57.03% | -68,5 -142 51.78% | -120 -60,3 -98.66% | -11,2 -64,6 82.7% | 229 183 25.1% | -3,65 |
EPS SEK | Released Forecast Spread | 1,00 0,64 56.25% | -0,78 -1,31 40.63% | -1,36 -0,68 -99.12% | -0,13 -0,72 81.84% | 2,59 2,09 24.22% | -0,06 |
Announcement Date | 06/02/20 | 04/02/21 | 03/02/22 | 03/02/23 | 14/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 2,75 3,00 -8.47% | 209 119 75.49% | 11,0 15,9 -30.67% | 29,6 18,2 62.81% | 49,6 | 357 | 108 | 147 | ||
EBIT Million SEK | Released Forecast Spread | -101 -94,0 -7.31% | 131 23,0 469.62% | -78,1 -67,8 -15.19% | -73,1 -81,8 10.59% | -79,9 | 218 | -50,7 | 13,8 | ||
Net income Million SEK | Released Forecast Spread | -44,3 | 294 | ||||||||
EPS SEK | Released Forecast Spread | -0,50 | 3,31 | -1,16 -0,98 -18.37% | 1,41 2,00 -29.5% | -0,99 -0,90 -10% | -0,65 -0,80 18.75% | -0,90 | 2,40 | -0,60 | 0,30 |
Announcement Date | 28/04/22 | 27/04/23 | 12/07/23 | 08/11/23 | 14/02/24 | 17/05/24 | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for BioArctic AB
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
- Calendar BioArctic AB